These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts. Calmy A; Petoumenos K; Lewden C; Law M; Bocquentin F; Hesse K; Cooper D; Carr A; Bonnet F; HIV Med; 2007 Apr; 8(3):171-80. PubMed ID: 17461861 [TBL] [Abstract][Full Text] [Related]
6. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384 [TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drugs and the risk of myocardial infarction. Zangerle R; Sarcletti M N Engl J Med; 2007 Aug; 357(7):715-6; author reply 716-7. PubMed ID: 17703532 [No Abstract] [Full Text] [Related]
8. Spring cleaning in trial land. Gilden D GMHC Treat Issues; 1997 Mar; 11(3):4-7. PubMed ID: 11364275 [TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors: opium of the masses? Martinez LJ Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167 [No Abstract] [Full Text] [Related]
10. The problem with antivirals alone. TreatmentUpdate; 1999 Mar; 11(2):1-2. PubMed ID: 11366774 [TBL] [Abstract][Full Text] [Related]
11. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection. Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM; Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958 [TBL] [Abstract][Full Text] [Related]
12. Protease inhibitors at a glance... Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198 [TBL] [Abstract][Full Text] [Related]
13. Triple PI therapy--perhaps more is not better. Jenny-Avital ER AIDS Clin Care; 2002 Dec; 14(12):105-6. PubMed ID: 12510655 [No Abstract] [Full Text] [Related]
14. Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects. Smith RJ; Wahl LM Bull Math Biol; 2004 Sep; 66(5):1259-83. PubMed ID: 15294425 [TBL] [Abstract][Full Text] [Related]
15. Soft gel saquinavir has high exposure. AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835 [TBL] [Abstract][Full Text] [Related]
16. Anti-HIV agents. Atazanavir as a booster for protease inhibitors. TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850 [No Abstract] [Full Text] [Related]
17. Conference updates show promising drug data. AIDS Alert; 1997 Nov; 12(11):125-6. PubMed ID: 11364769 [TBL] [Abstract][Full Text] [Related]
18. [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():44. PubMed ID: 15373047 [No Abstract] [Full Text] [Related]
19. HIV: it's beginning to look like a chronic disease. del Rio C AIDS Clin Care; 2001 Sep; 13(9):82-3. PubMed ID: 11547601 [No Abstract] [Full Text] [Related]
20. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ; Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]